Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118284478 | 11828447 | 8 | F | 20160229 | 20160926 | 20151211 | 20160930 | EXP | US-PFIZER INC-2015431981 | PFIZER | 65.00 | YR | M | Y | 109.00000 | KG | 20160930 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118284478 | 11828447 | 1 | PS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | UNK | Y | 20702 | ||||||||||
| 118284478 | 11828447 | 2 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | UNK | Y | 12151 | TABLET | |||||||||
| 118284478 | 11828447 | 3 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | UNK | Y | 74133 | ||||||||||
| 118284478 | 11828447 | 4 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | 20 MG, UNK | Y | 75241 | 20 | MG | SOLUTION FOR INJECTION | |||||||
| 118284478 | 11828447 | 5 | SS | BRILINTA | TICAGRELOR | 1 | UNK | Y | 0 | ||||||||||
| 118284478 | 11828447 | 6 | SS | BABY ASPIRIN | ASPIRIN | 1 | 81 MG, UNK | Y | 0 | 81 | MG | ||||||||
| 118284478 | 11828447 | 7 | SS | TRADJENTA | LINAGLIPTIN | 1 | UNK | Y | 0 | ||||||||||
| 118284478 | 11828447 | 8 | SS | FLUOXETINE HYDROCHLORIDE. | FLUOXETINE HYDROCHLORIDE | 1 | 30 MG, UNK | 0 | 30 | MG | |||||||||
| 118284478 | 11828447 | 9 | SS | LISINOPRIL. | LISINOPRIL | 1 | UNK | Y | 0 | ||||||||||
| 118284478 | 11828447 | 10 | SS | WARFARIN | WARFARIN | 1 | UNK | Y | 0 | ||||||||||
| 118284478 | 11828447 | 11 | C | COUMADIN | WARFARIN SODIUM | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 12 | C | LASIX | FUROSEMIDE | 1 | 80 MG, 2X/DAY | 0 | 80 | MG | BID | ||||||||
| 118284478 | 11828447 | 13 | C | LASIX | FUROSEMIDE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 118284478 | 11828447 | 14 | C | VANCOMYCIN | VANCOMYCIN | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 15 | C | DIGOXIN. | DIGOXIN | 1 | UNK, 2X/DAY | 0 | BID | ||||||||||
| 118284478 | 11828447 | 16 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, UNK | 0 | 81 | MG | |||||||||
| 118284478 | 11828447 | 17 | C | POTASSIUM | POTASSIUM | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 18 | C | IRON | IRON | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 19 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | 30 MG, UNK | 0 | 30 | MG | |||||||||
| 118284478 | 11828447 | 20 | C | PEPCID | FAMOTIDINE | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 21 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 22 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 23 | C | MVI | VITAMINS | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 24 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 25 | C | HYDROCODONE | HYDROCODONE | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 26 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 27 | C | PROBIOTIC | PROBIOTICS NOS | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 28 | C | AFRIN | OXYMETAZOLINE | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 29 | C | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 30 | C | MUCINEX | GUAIFENESIN | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 31 | C | TRUBIOTICS ONE A DAY | 2 | UNK | 0 | ||||||||||||
| 118284478 | 11828447 | 32 | C | JUVEN | .BETA.-HYDROXYISOVALERIC ACIDARGININEGLUTAMINE | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 33 | C | DICYCLOMINE | DICYCLOMINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 34 | C | ONDANSETRON | ONDANSETRON | 1 | UNK | 0 | |||||||||||
| 118284478 | 11828447 | 35 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118284478 | 11828447 | 1 | Blood cholesterol abnormal |
| 118284478 | 11828447 | 8 | Depression |
| 118284478 | 11828447 | 12 | Swelling |
| 118284478 | 11828447 | 33 | Abdominal pain |
| 118284478 | 11828447 | 34 | Nausea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118284478 | 11828447 | OT |
| 118284478 | 11828447 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118284478 | 11828447 | Abdominal infection | |
| 118284478 | 11828447 | Abdominal pain upper | |
| 118284478 | 11828447 | Blood pressure decreased | |
| 118284478 | 11828447 | Body temperature decreased | |
| 118284478 | 11828447 | Brain natriuretic peptide increased | |
| 118284478 | 11828447 | Clostridium difficile infection | |
| 118284478 | 11828447 | Constipation | |
| 118284478 | 11828447 | Decubitus ulcer | |
| 118284478 | 11828447 | Diarrhoea | |
| 118284478 | 11828447 | Dysgeusia | |
| 118284478 | 11828447 | Dysphagia | |
| 118284478 | 11828447 | Haematoma | |
| 118284478 | 11828447 | Haemoglobin decreased | |
| 118284478 | 11828447 | Hyperventilation | |
| 118284478 | 11828447 | Impaired healing | |
| 118284478 | 11828447 | Injury | |
| 118284478 | 11828447 | Internal haemorrhage | |
| 118284478 | 11828447 | Musculoskeletal discomfort | |
| 118284478 | 11828447 | Nephrolithiasis | |
| 118284478 | 11828447 | Oedema | |
| 118284478 | 11828447 | Peritoneal abscess | |
| 118284478 | 11828447 | Peritoneal haematoma | |
| 118284478 | 11828447 | Protein total decreased | |
| 118284478 | 11828447 | Rotator cuff syndrome | |
| 118284478 | 11828447 | Sepsis | |
| 118284478 | 11828447 | Sinusitis | |
| 118284478 | 11828447 | Skin ulcer | |
| 118284478 | 11828447 | Skin wound | |
| 118284478 | 11828447 | Thrombosis | |
| 118284478 | 11828447 | Urine output decreased | |
| 118284478 | 11828447 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118284478 | 11828447 | 4 | 20160910 | 0 | ||
| 118284478 | 11828447 | 8 | 20160418 | 0 | ||
| 118284478 | 11828447 | 11 | 20160219 | 0 | ||
| 118284478 | 11828447 | 13 | 20160910 | 0 | ||
| 118284478 | 11828447 | 14 | 201604 | 0 |